Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
LaunchTeva Pharmaceutical Industries Ltd. announces a strategic collaboration for the commercialization of Formycon's biosimilar candidate FYB203 in Europe and Israel.
Jan 13, 2025
Tel AvivManufacturingBiotechnologyHealth CareTherapeuticsPharmaceutical
Product Description
Teva Pharmaceuticals International GmbH has entered a strategic collaboration with Klinge Biopharma GmbH and Formycon AG for the semi-exclusive commercialization of FYB203, a biosimilar candidate to Eylea®, across Europe and Israel, leveraging Teva’s commercial experience and distribution network in the region.
Company Information
Company
Teva Pharmaceutical Industries Ltd
Location
Tel Aviv, Tel Aviv District, Israel
About
Teva Pharmaceutical Industries Ltd. is a leading global pharmaceutical company that delivers high-quality, patient-centric healthcare solutions to millions of people worldwide. With a focus on innovative medicines, especially in areas of central nervous system, pain, and respiratory therapies, Teva is dedicated to improving health and increasing access to medicines around the world.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Teva Pharmaceutical Industries Ltd ships something new, hires an exec or expands, usually minutes after it happens, and tells you who to reach.